This story has been updated from a previous version.

NEW YORK, July 18 - With its sights set on joining the ranks of big pharma--at least in the field of oncology--Exelixis said Wednesday that it had signed a far-reaching deal with Bristol-Myers Squibb to jointly discover potential drug targets for cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.